-
www.innovations.ahrq.gov/policymakers/chipra/overview/background/methods.html
December 01, 2009 - In addition, SNAC members were invited to nominate additional measures for consideration. … Authors of the CHIPRA-commissioned papers also recommended measures for consideration and additional … Lowest scoring measures were eliminated from further consideration. … This process resulted in 31 measures for final consideration on the second day of the meeting. … Return to Contents
Additional Consideration of SNAC-Recommended Measures
Several rounds of review
-
www.monahrq.ahrq.gov/policymakers/chipra/overview/background/methods.html
December 01, 2009 - In addition, SNAC members were invited to nominate additional measures for consideration. … Authors of the CHIPRA-commissioned papers also recommended measures for consideration and additional … Lowest scoring measures were eliminated from further consideration. … This process resulted in 31 measures for final consideration on the second day of the meeting. … Return to Contents
Additional Consideration of SNAC-Recommended Measures
Several rounds of review
-
www.healthcare411.ahrq.gov/policymakers/chipra/overview/background/methods.html
December 01, 2009 - In addition, SNAC members were invited to nominate additional measures for consideration. … Authors of the CHIPRA-commissioned papers also recommended measures for consideration and additional … Lowest scoring measures were eliminated from further consideration. … This process resulted in 31 measures for final consideration on the second day of the meeting. … Return to Contents
Additional Consideration of SNAC-Recommended Measures
Several rounds of review
-
www.qualitymeasures.ahrq.gov/policymakers/chipra/overview/background/methods.html
December 01, 2009 - In addition, SNAC members were invited to nominate additional measures for consideration. … Authors of the CHIPRA-commissioned papers also recommended measures for consideration and additional … Lowest scoring measures were eliminated from further consideration. … This process resulted in 31 measures for final consideration on the second day of the meeting. … Return to Contents
Additional Consideration of SNAC-Recommended Measures
Several rounds of review
-
www.talkingquality.ahrq.gov/policymakers/chipra/overview/background/methods.html
December 01, 2009 - In addition, SNAC members were invited to nominate additional measures for consideration. … Authors of the CHIPRA-commissioned papers also recommended measures for consideration and additional … Lowest scoring measures were eliminated from further consideration. … This process resulted in 31 measures for final consideration on the second day of the meeting. … Return to Contents
Additional Consideration of SNAC-Recommended Measures
Several rounds of review
-
ce.effectivehealthcare.ahrq.gov/policymakers/chipra/overview/background/methods.html
December 01, 2009 - In addition, SNAC members were invited to nominate additional measures for consideration. … Authors of the CHIPRA-commissioned papers also recommended measures for consideration and additional … Lowest scoring measures were eliminated from further consideration. … This process resulted in 31 measures for final consideration on the second day of the meeting. … Return to Contents
Additional Consideration of SNAC-Recommended Measures
Several rounds of review
-
www.ahrq.gov/prevention/guidelines/guide/appendix-d.html
June 01, 2014 - Anyone can nominate a topic for consideration by the Task Force. … Force Web site ( www.USPreventiveServicesTaskForce.org ) to learn how and when to nominate topics for consideration … Nominate a new USPSTF member or a topic for a consideration by the Task Force.
-
healthcare411.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/perinatal-care/modules/strategies/medication/safemed_facguide.pdf
May 01, 2017 - Administration 7
SAY:
The second consideration for Safe Medication
Administration of Oxytocin is … Administration 9
SAY:
The fourth consideration for Safe Medication
Administration of Oxytocin is … Administration 10
SAY:
The fifth consideration for Safe Medication
Administration of Oxytocin is … Administration 13
SAY:
The first consideration for Safe Medication
Administration of Magnesium is … Administration 15
SAY:
The second consideration for Safe Medication
Administration of Magnesium
-
cahps.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/perinatal-care/modules/strategies/medication/safemed_facguide.pdf
May 01, 2017 - Administration 7
SAY:
The second consideration for Safe Medication
Administration of Oxytocin is … Administration 9
SAY:
The fourth consideration for Safe Medication
Administration of Oxytocin is … Administration 10
SAY:
The fifth consideration for Safe Medication
Administration of Oxytocin is … Administration 13
SAY:
The first consideration for Safe Medication
Administration of Magnesium is … Administration 15
SAY:
The second consideration for Safe Medication
Administration of Magnesium
-
monahrq.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/perinatal-care/modules/strategies/medication/safemed_facguide.pdf
May 01, 2017 - Administration 7
SAY:
The second consideration for Safe Medication
Administration of Oxytocin is … Administration 9
SAY:
The fourth consideration for Safe Medication
Administration of Oxytocin is … Administration 10
SAY:
The fifth consideration for Safe Medication
Administration of Oxytocin is … Administration 13
SAY:
The first consideration for Safe Medication
Administration of Magnesium is … Administration 15
SAY:
The second consideration for Safe Medication
Administration of Magnesium
-
talkingquality.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/perinatal-care/modules/strategies/medication/safemed_facguide.pdf
May 01, 2017 - Administration 7
SAY:
The second consideration for Safe Medication
Administration of Oxytocin is … Administration 9
SAY:
The fourth consideration for Safe Medication
Administration of Oxytocin is … Administration 10
SAY:
The fifth consideration for Safe Medication
Administration of Oxytocin is … Administration 13
SAY:
The first consideration for Safe Medication
Administration of Magnesium is … Administration 15
SAY:
The second consideration for Safe Medication
Administration of Magnesium
-
pbrn.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/perinatal-care/modules/strategies/medication/safemed_facguide.pdf
May 01, 2017 - Administration 7
SAY:
The second consideration for Safe Medication
Administration of Oxytocin is … Administration 9
SAY:
The fourth consideration for Safe Medication
Administration of Oxytocin is … Administration 10
SAY:
The fifth consideration for Safe Medication
Administration of Oxytocin is … Administration 13
SAY:
The first consideration for Safe Medication
Administration of Magnesium is … Administration 15
SAY:
The second consideration for Safe Medication
Administration of Magnesium
-
pcmh.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/perinatal-care/modules/strategies/medication/safemed_facguide.pdf
May 01, 2017 - Administration 7
SAY:
The second consideration for Safe Medication
Administration of Oxytocin is … Administration 9
SAY:
The fourth consideration for Safe Medication
Administration of Oxytocin is … Administration 10
SAY:
The fifth consideration for Safe Medication
Administration of Oxytocin is … Administration 13
SAY:
The first consideration for Safe Medication
Administration of Magnesium is … Administration 15
SAY:
The second consideration for Safe Medication
Administration of Magnesium
-
patientregistry.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/perinatal-care/modules/strategies/medication/safemed_facguide.pdf
May 01, 2017 - Administration 7
SAY:
The second consideration for Safe Medication
Administration of Oxytocin is … Administration 9
SAY:
The fourth consideration for Safe Medication
Administration of Oxytocin is … Administration 10
SAY:
The fifth consideration for Safe Medication
Administration of Oxytocin is … Administration 13
SAY:
The first consideration for Safe Medication
Administration of Magnesium is … Administration 15
SAY:
The second consideration for Safe Medication
Administration of Magnesium
-
ahrqpubs.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/perinatal-care/modules/strategies/medication/safemed_facguide.pdf
May 01, 2017 - Administration 7
SAY:
The second consideration for Safe Medication
Administration of Oxytocin is … Administration 9
SAY:
The fourth consideration for Safe Medication
Administration of Oxytocin is … Administration 10
SAY:
The fifth consideration for Safe Medication
Administration of Oxytocin is … Administration 13
SAY:
The first consideration for Safe Medication
Administration of Magnesium is … Administration 15
SAY:
The second consideration for Safe Medication
Administration of Magnesium
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/perinatal-care/modules/strategies/medication/safemed_facguide.pdf
May 01, 2017 - Administration 7
SAY:
The second consideration for Safe Medication
Administration of Oxytocin is … Administration 9
SAY:
The fourth consideration for Safe Medication
Administration of Oxytocin is … Administration 10
SAY:
The fifth consideration for Safe Medication
Administration of Oxytocin is … Administration 13
SAY:
The first consideration for Safe Medication
Administration of Magnesium is … Administration 15
SAY:
The second consideration for Safe Medication
Administration of Magnesium
-
www.ahrq.gov/policymakers/chipra/pubs/background-2012/index.html
December 01, 2012 - Results: In all, 77 measures were submitted for consideration by the SNAC; 64 by the public and 13 by … Thus, the information submitted to support consideration of measures varied. … In consideration of the limited time SNAC members had for scoring substantial numbers of measures on … In addition, COEs were encouraged to submit measures for consideration by the SNAC, and three of the … set and other purposes, for a total of 13 measures for such consideration.
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/does-the-use-of-cytochrome-p450-2c19-cyp2c19-testing-to-predict-response-to-clopidogrel-in-people-1-with-acute-coronary-syndrome-2-who-have-suffered-other-cardiovascular-disease-related-events-eg-ischemic-stroke-symptomatic-p
August 04, 2010 - This is a topic under consideration by the EGAPP Working Group, who may develop evidence-based guidelines … This is a topic under consideration by the EGAPP Working Group, who may develop evidence-based guidelines … role or perspective: (you may select more than one category if appropriate)
This is a topic under consideration
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/2024-01/joseph2-report.pdf
January 01, 2024 - Several questions were
removed from further consideration, because more than 70% respondents indicated … • Indicate multiple building categories for one design consideration. … • Users were asked to record their evaluation about each design consideration (i.e., estimated risk … Decision on whether to implement a particular design consideration (e.g., yes, maybe,
no), which was … Post-Pilot – this was moved to
allow the consideration and notes to be adjacent to one another.
3.
-
pcmh.ahrq.gov/funding/process/award-process/index.html
June 01, 2017 - Several factors are taken into consideration, including:
Reviewers' priority or percentile score for … After careful review, an application may be presented for funding consideration along with other applications